Replimune Group Inc (NASDAQ: REPL) Hogging The Spotlight Today
##### Currently, there are 77.09M common shares owned by the public and among those 62.53M shares have been available to trade. ##### ##### ##### The company’s stock has a 5-day price change of -77.38% and -68.00% over the past three months. REPL shares are trading -72.12% year to date (YTD), with the 12-month market performance […]
Replimune Group Inc (REPL) Testing Investors’ Patience Right Now
Currently, there are 77.09M common shares owned by the public and among those 62.53M shares have been available to trade. The company’s stock has a 5-day price change of 32.76% and 68.71% over the past three months. REPL shares are trading 25.00% year to date (YTD), with the 12-month market performance up to 2.39% higher. […]
Replimune Group Inc (REPL) Outlook Starting To Look Brighter?
Replimune Group Inc (REPL) concluded trading on Thursday at a closing price of $7.66, with 2.66 million shares of worth about $20.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -59.26% during that period and on Thursday the price saw a gain of […]
Analysts Update Their Price Forecasts For Replimune Group Inc (REPL)
T. Rowe Price Associates, Inc. has recently announced that it has increased stake in Replimune Group Inc (NASDAQ:REPL) by 0.94%. After grabbing 5.67 million shares, the institutional investor is now in possession of 52966.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.60% having worth around $63.35 million. […]